The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Somalia seeks to expand partnership with Brazil
- Brazil and Sudan discuss trade
- Brazil-Arab Gallery #65
- Oil rises amid Middle East instability
- Zayed Prize sees 32% increase in applications
- Arab-Brazilian Chamber holds Gulf talks
- Mauritania opens to Brazilian cattle embryos
- Invest Minas, Arab-Brazilian Chamber discuss ties

